Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy A Lequeux, MZ Noman, M Xiao, K Van Moer, M Hasmim, A Benoit, ... Oncogene 40 (28), 4725-4735, 2021 | 101 | 2021 |
Advanced co-culture 3D breast cancer model for investigation of fibrosis induced by external stimuli: optimization study I Yakavets, A Francois, A Benoit, JL Merlin, L Bezdetnaya, G Vogin Scientific reports 10 (1), 21273, 2020 | 91 | 2020 |
Targeting cytoprotective autophagy to enhance anticancer therapies M Xiao, A Benoit, M Hasmim, C Duhem, G Vogin, G Berchem, MZ Noman, ... Frontiers in Oncology 11, 626309, 2021 | 30 | 2021 |
Lighting up the fire in the microenvironment of cold tumors: A major challenge to improve cancer immunotherapy A Benoit, G Vogin, C Duhem, G Berchem, B Janji Cells 12 (13), 1787, 2023 | 21 | 2023 |
Atypical chemokine receptor 2 expression is directly regulated by hypoxia inducible factor-1 alpha in cancer cells under hypoxia A Benoit, A Lequeux, P Harter, G Berchem, B Janji Scientific Reports 14 (1), 26589, 2024 | | 2024 |
Identification du rôle de l’hypoxie dépendante de HIF-1α dans la régulation de l’expression de ACKR2 (Atypical Chemokine Receptor 2) dans le cancer A Benoit Université de Lorraine, 2024 | | 2024 |